Full text is available at the source.
Chemical modifications of nucleic acid drugs and their delivery systems for gene‐based therapy
Chemical changes in genetic drugs and how they are delivered for gene therapy
AI simplified
Abstract
Gene-based therapy is a crucial approach in precision medicine that targets specific genes in specific cells.
- Key challenges for clinical applications of gene-based therapy include safety, stability, selectivity, delivery, and immune responses.
- Current nucleic acid drugs in clinical trials and on the market include antisense oligonucleotides, siRNA, aptamers, and plasmid nucleic acids.
- Chemical modifications of nucleic acid drugs may enhance their effectiveness and delivery systems for therapeutic use.
- Nanotechnology methods are being explored to improve the delivery of nucleic acid drugs in vivo.
AI simplified